The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $64.70

Today's change+0.80 +1.25%
Updated November 26 4:02 PM EST. Delayed by at least 15 minutes.
 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $64.70

Today's change+0.80 +1.25%
Updated November 26 4:02 PM EST. Delayed by at least 15 minutes.

MEDNAX Inc up (U.S.)$0.80

MEDNAX Inc closed up Wednesday by (U.S.)$0.80 or 1.25% to (U.S.)$64.70. Over the last five days, shares have gained 1.41% and 21.21% year to date. Shares have outperformed the S&P 500 by 2.27% during the last year.

Key company metrics

  • Open(U.S.) $63.84
  • Previous close(U.S.) $63.90
  • High(U.S.) $64.88
  • Low(U.S.) $63.84
  • Bid / Ask-- / --
  • YTD % change+21.21%
  • Volume442,400
  • Average volume (10-day)705,400
  • Average volume (1-month)751,545
  • Average volume (3-month)675,744
  • 52-week range(U.S.) $49.82 to (U.S.) $65.31
  • Beta0.71
  • Trailing P/E21.07×
  • P/E 1 year forward20.56×
  • Forward PEG1.53×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.07
Updated November 26 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+13.07%

Based on its net profit margin of 13.07%, MEDNAX Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.77%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue627596566567
Total other revenue--------
Total revenue627596566567
Gross profit210201173190
Total cost of revenue416395393377
Total operating expense488466462443
Selling / general / administrative61615856
Research & development--------
Depreciation / amortization11101010
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income138130104124
Interest income (expense), net non-operating-2-2-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax137128104123
Income after tax86796479
Income tax, total51494144
Net income86796479
Total adjustments to net income--------
Net income before extra. items86796479
Minority interest000--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items86796479
Inc. avail. to common incl. extra. items86796479
Diluted net income86796479
Dilution adjustment------0
Diluted weighted average shares100100100101
Diluted EPS excluding extraordinary itemsvalue per share0.860.790.640.78
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.860.790.640.78